ANIP  valuation analysis

Basics
Name: ANI Pharmaceuticals, Inc
Description: ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 07, 2021
Market cap: $420.65M (1385th)
Sales(TTM): $213.22M (1348th)
Earnings(TTM): -$15.45M (1170th)

Value
FFER: 0.63*
Actual price: $32.98
* Earnings were reported Aug 04, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • ANI Pharmaceuticals, Inc's operating income decreased from $4.18M to -$4.68M in the last year.
Earnings / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
ANI Pharmaceuticals, Inc
"Drug Manufacturers-Specialty & Generic" industry